HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
2-(Indol-3-yl)ethylaminhydrochlorid
TRYPTAMINE HCL · TIMTEC-BB SBB000359 · Triptamine hydrochloride · Tryptamine hydrochloride · TYRAMINE Hydrochloride D4 · 3-(2-AMINOETHYL)INDOLE HCL · TryptaMine hydrochloride 99% · Tryptamine Hydrochloride >Tryptamine hydrochloride, 98+%
Identifikatoren & physikalische Daten
| CAS No. | 343-94-2 |
|---|---|
| Summenformel | C10H13ClN2 |
| Durchschnittliche Molmasse | 196,68 g/mol |
| SMILES | [Cl-].[NH3+]CCc1c[nH]c2ccccc12 |
| InChIKey | KDFBGNBTTMPNIG-UHFFFAOYSA-N |
| PubChem CID | 10856417 |
| Lokaler Name | 2-(Indol-3-yl)ethylaminhydrochlorid |
Chemische & physikalische Eigenschaften
| Schmelzpunkt | 253-255 °C(lit.) |
|---|---|
| Lagerbedingungen | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| Löslichkeit | water: soluble0.1g/10 mL, clear to slightly hazy, colorless to yellowwater: soluble 0.1g/10 mL, clear to slightly hazy, colorless to yellow |
| Aggregatzustand | Powder |
| Farbe | Beige to light orange |
| Merck | 14,9796 |
| BRN | 3568419 |
| Stabilität | Hygroscopic |
| InChI | InChI=1S/C10H12N2.ClH/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2 |
| InChIKey | KDFBGNBTTMPNIG-UHFFFAOYSA-N |
| SMILES | C12C=CC=CC=1NC=C2CCN.Cl |
| CAS Datenbank | 343-94-2(CAS DataBase Reference) |
| EPA chemische Informationen | 1H-Indole-3-ethanamine, monohydrochloride (343-94-2) |
Sicherheit & Vorschriften
| F | 3-8-10 |
|---|---|
| Wassergefährdungsklasse (WGK) | 3 |
| TSCA-Inventar-Status | TSCA listed |
| Zollcode | 29339900 |
| RTECS-Nr. | NL4375000 |
| R-Sätze (R) | 36/37/38-20/21/22-41-37/38-22 |
| Gefahrensymbole | Xn,Xi |
| Sicherheitshinweise (S) | 22-24/25-36/37/39-36-26 |
| Lagerklasse | 11 - Combustible Solids |
| Gefahrenklasse | Acute Tox. 4 OralEye Dam. 1Skin Sens. 1A |
Anwendungen & Verwendung
Verwenden
Reactant for preparation of:Tryptamine derivatives as inhibitors against hepatitis B virusCarbamoyl epipodophyllotoxins as potential antitumor agentsAnthranilic acid derivatives as CCK receptor antagonistsBrassinin derivatives as indoleamine 2,3-dioxygenase inhibitorsAntispasmodic agentsβ-carbolinium cations as new antimalarial agents